{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:08:48Z","timestamp":1774429728911,"version":"3.50.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajog.2025.01.044","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T11:51:48Z","timestamp":1738842708000},"page":"506-523.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Anti-M\u00fcllerian hormone as a diagnostic marker of polycystic ovary syndrome: a systematic review with meta-analysis"],"prefix":"10.1016","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9426-401X","authenticated-orcid":false,"given":"Mariane de Oliveira","family":"Gomes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliane de Oliveira","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Fernandes","family":"Ananias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo Augusto","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Seiji","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula","family":"Espindula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2025.01.044_bib1","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2025.01.044_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.01.044_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.23736\/S0026-4784.19.04404-6","article-title":"Criteria, phenotypes and prevalence of polycystic ovary syndrome","volume":"71","author":"Belenkaia","year":"2019","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.ajog.2025.01.044_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","article-title":"Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy","volume":"182","author":"Patel","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ajog.2025.01.044_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2025.01.044_bib6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/cen.13517","article-title":"Anti-M\u00fcllerian hormone measurement for the diagnosis of polycystic ovary syndrome","volume":"88","author":"Sathyapalan","year":"2018","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ajog.2025.01.044_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fendo.2020.00641","article-title":"Role of anti-m\u00fcllerian hormone in the pathogenesis of polycystic ovary syndrome","volume":"11","author":"Dewailly","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ajog.2025.01.044_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12902-020-00569-6","article-title":"Role of anti-m\u00fcllerian hormone and testosterone in follicular growth: a cross-sectional study","volume":"20","author":"Lv","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.ajog.2025.01.044_bib9","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.fertnstert.2009.11.002","article-title":"Serum Antimullerian Hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)","volume":"94","author":"Hart","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2025.01.044_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/cen.13269","article-title":"Anti-M\u00fcllerian hormone reflects the severity of polycystic ovary syndrome","volume":"86","author":"Jacob","year":"2017","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ajog.2025.01.044_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203129","article-title":"Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women","volume":"13","author":"Yue","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2025.01.044_bib12","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2025.01.044_bib13","series-title":"Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy","year":"2023"},{"key":"10.1016\/j.ajog.2025.01.044_bib14","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2025.01.044_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ecl.2020.10.002","article-title":"Diagnosis of polycystic ovary syndrome: which criteria to use and when?","volume":"50","author":"Chang","year":"2021","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ajog.2025.01.044_bib16","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2025.01.044_bib17","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2025.01.044_bib18","series-title":"Revis\u00f5es sistem\u00e1ticas da Literatura: guia pr\u00e1tico","author":"De Luca Canto","year":"2020"},{"key":"10.1016\/j.ajog.2025.01.044_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.ajog.2025.01.044_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2025.01.044_bib22","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2025.01.044_bib23","series-title":"GRADE handbook for grading quality of evidence and strength of recommendations","author":"Sch\u00fcnemann","year":"2013"},{"key":"10.1016\/j.ajog.2025.01.044_bib24","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3389\/fendo.2019.00656","article-title":"Anti-M\u00fcllerian hormone (AMH) in the diagnosis of menstrual disturbance due to polycystic ovarian syndrome","volume":"10","author":"Abbara","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ajog.2025.01.044_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/diagnostics9040136","article-title":"Serum anti-m\u00fcllerian hormone in the diagnosis of polycystic ovary syndrome in association with clinical symptoms","volume":"9","author":"Ahmed","year":"2019","journal-title":"Diagnostics"},{"key":"10.1016\/j.ajog.2025.01.044_bib26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2147\/IJWH.S403347","article-title":"Diagnostic performance of anti-m\u00fcllerian hormone, luteinizing hormone to follicle-stimulating hormone ratio, testosterone, and prolactin to predict polycystic ovary syndrome among Sudanese women","volume":"15","author":"Alhassan","year":"2023","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.ajog.2025.01.044_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.51253\/pafmj.v73i2.4249","article-title":"Diagnostic accuracy of anti-mullerian hormone for polycystic ovary syndrome","volume":"73","author":"Bahadur","year":"2023","journal-title":"Pak Armed Forces Med J"},{"key":"10.1016\/j.ajog.2025.01.044_bib28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1515\/jomb-2017-0068","article-title":"Anti-M\u00fcllerian hormone as a diagnostic marker in Egyptian infertile polycystic ovary syndrome females: correlations with vitamin D, total testosterone, dyslipidemia and anthropometric parameters","volume":"37","author":"Bakeer","year":"2018","journal-title":"J Med Biochem"},{"key":"10.1016\/j.ajog.2025.01.044_bib29","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.rbmo.2019.04.002","article-title":"Anti-M\u00fcllerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population","volume":"39","author":"Bozdag","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2025.01.044_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4158\/EP15903.OR","article-title":"Amh measurement versus ovarian ultrasound in the diagnosis of polycystic ovary syndrome in different phenotypes","volume":"22","author":"Carmina","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ajog.2025.01.044_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00404-015-3889-5","article-title":"Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria","volume":"293","author":"Jamil","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2025.01.044_bib32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ijgo.13515","article-title":"Age-related diagnostic threshold of anti-M\u00fcllerian hormone for polycystic ovarian syndrome","volume":"153","author":"Kakkad","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2025.01.044_bib33","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00404-014-3317-2","article-title":"Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome","volume":"290","author":"K\u00f6ninger","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2025.01.044_bib34","first-page":"98","article-title":"Comparative evaluation of diagnostic efficacy of serum Anti-M\u00fcllerian hormone and ultrasound in polycystic ovarian syndrome","volume":"10","author":"Kumari","year":"2018","journal-title":"J S Asian Fed Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.01.044_bib35","first-page":"1","article-title":"Anti-Mullerian hormone (AMH) as a useful marker in diagnosis of polycystic ovary syndrome","volume":"3","author":"Leonte","year":"2007","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.ajog.2025.01.044_bib36","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10815-012-9839-2","article-title":"Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism","volume":"29","author":"Li","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.ajog.2025.01.044_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mefs.2015.06.003","article-title":"The relationship between Anti-m\u00fcllerian hormone and the clinical, biochemical and sonographic parameters in women with polycystic ovarian syndrome","volume":"21","author":"Mahran","year":"2016","journal-title":"Middle East Fertil Soc J"},{"key":"10.1016\/j.ajog.2025.01.044_bib38","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1007\/s43032-023-01195-y","article-title":"Serum anti-mullerian hormone (AMH) levels among different PCOS phenotypes and its correlation with clinical, endocrine, and metabolic markers of PCOS","volume":"30","author":"Malhotra","year":"2023","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2025.01.044_bib39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1507\/endocrj.EJ16-0501","article-title":"Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome","volume":"64","author":"Matsuzaki","year":"2017","journal-title":"Endocr J"},{"key":"10.1016\/j.ajog.2025.01.044_bib40","doi-asserted-by":"crossref","DOI":"10.1080\/09513590.2023.2247098","article-title":"The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome","volume":"39","author":"Moursi","year":"2023","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2025.01.044_bib41","first-page":"32","article-title":"The relation between serum anti-Mullerian hormone levels and follicle count in polycystic ovary syndrome","volume":"4","author":"Tanridan","year":"2017","journal-title":"The European Research Journal"},{"key":"10.1016\/j.ajog.2025.01.044_bib42","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/cen.13415","article-title":"Age-stratified thresholds of anti-M\u00fcllerian hormone improve prediction of polycystic ovary syndrome over a population-based threshold","volume":"87","author":"Quinn","year":"2017","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ajog.2025.01.044_bib43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12958-021-00755-8","article-title":"Age-specific cut-off levels of anti-M\u00fcllerian hormone can be used as diagnostic markers for polycystic ovary syndrome","volume":"19","author":"Ramezani Tehrani","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ajog.2025.01.044_bib44","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2147\/DMSO.S299558","article-title":"The relationship of anti-mullerian hormone in polycystic ovary syndrome patients with different subgroups","volume":"14","author":"Ran","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.ajog.2025.01.044_bib45","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1590\/2359-3997000000215","article-title":"Age related endocrine patterns observed in polycystic ovary syndrome patients vs. ovulatory controls: descriptive data from a university based infertility center","volume":"60","author":"Rashidi","year":"2016","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.ajog.2025.01.044_bib46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4103\/MJBL.MJBL_98_18","article-title":"Anti-m\u00fcllerian hormone level in patients with polycystic ovary syndrome","volume":"15","author":"Saadullah","year":"2018","journal-title":"Medical Journal of Babylon"},{"key":"10.1016\/j.ajog.2025.01.044_bib47","first-page":"564","article-title":"Anti-mullerian hormone (AMH) levels in women with and without polycystic ovary syndrome (PCOS)","volume":"12","author":"Sadiq","year":"2018","journal-title":"Pakistan J Med Health Sci"},{"key":"10.1016\/j.ajog.2025.01.044_bib48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejogrb.2013.05.019","article-title":"Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome","volume":"170","author":"Sahmay","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2025.01.044_bib49","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/aogs.12247","article-title":"Elevated serum levels of anti-M\u00fcllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome","volume":"92","author":"Sahmay","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2025.01.044_bib50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10815-013-0149-0","article-title":"Diagnosis of polycystic ovary syndrome: AMH in combination with clinical symptoms","volume":"31","author":"Sahmay","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.ajog.2025.01.044_bib51","first-page":"1866","article-title":"Anti mullerian hormone: a potential marker for recruited non growing follicle of ovarian pool in women with polycystic ovarian syndrome","volume":"7","author":"Saikumar","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.ajog.2025.01.044_bib52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13224-017-1066-4","article-title":"Role of AMH as diagnostic tool for polycystic ovarian syndrome","volume":"68","author":"Saxena","year":"2018","journal-title":"J Obstet Gynaecol India"},{"key":"10.1016\/j.ajog.2025.01.044_bib53","first-page":"175","article-title":"Anti-m\u00fcllerian hormone as a surrogate marker for hormonal dysfunction and sonographic pattern in polycystic ovarian syndrome","volume":"11","author":"Sharma","year":"2019","journal-title":"J S Asian Fed Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.01.044_bib54","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/labmed\/lmy068","article-title":"Advantages of serum anti-m\u00fcllerian hormone as a marker for polycystic ovarian syndrome","volume":"50","author":"Shi","year":"2019","journal-title":"Lab Med"},{"key":"10.1016\/j.ajog.2025.01.044_bib55","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.18203\/2320-1770.ijrcog20203847","article-title":"Role of anti-mullerian hormone as a diagnostic tool for polycystic ovary syndrome","volume":"9","author":"Singh","year":"2020","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.01.044_bib56","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3904\/kjim.2016.038","article-title":"Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-M\u00fcllerian hormone cutoff value","volume":"32","author":"Song","year":"2017","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.ajog.2025.01.044_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23861","article-title":"Age-group-specific reference intervals for anti-M\u00fcllerian hormone and its diagnostic performance for polycystic ovary syndrome in a Korean population","volume":"35","author":"Song","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.ajog.2025.01.044_bib58","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12291-022-01058-4","article-title":"Efficacy of serum anti-mullerian hormone (AMH) levels for prediction of polycystic ovary syndrome (PCOS) and its association with clinical, biochemical and hormonal parameters","volume":"38","author":"Sumji","year":"2023","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.ajog.2025.01.044_bib59","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/03007995.2023.2204768","article-title":"Determining the age group-based cut-off values of serum anti-Mullerian hormone concentrations to diagnose polycystic ovary syndrome","volume":"39","author":"Timur","year":"2023","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ajog.2025.01.044_bib60","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/ajo.12366","article-title":"Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan","volume":"55","author":"Tremellen","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2025.01.044_bib61","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00404-022-06874-w","article-title":"The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology","volume":"307","author":"Vural","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2025.01.044_bib62","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10815-014-0300-6","article-title":"Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients","volume":"31","author":"Wiweko","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.ajog.2025.01.044_bib63","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tjog.2018.06.004","article-title":"Accuracy of anti-M\u00fcllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women","volume":"57","author":"Wongwananuruk","year":"2018","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.01.044_bib64","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1507\/endocrj.EJ12-0055","article-title":"Differences of the association of anti-M\u00fcllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome","volume":"59","author":"Woo","year":"2012","journal-title":"Endocr J"},{"key":"10.1016\/j.ajog.2025.01.044_bib65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12958-023-01064-y","article-title":"The reference value of anti-M\u00fcllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study","volume":"21","author":"Zhang","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ajog.2025.01.044_bib67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1590\/S0066-782X2009000300013","article-title":"Revis\u00e3o sistem\u00e1tica e meta-an\u00e1lise de estudos de diagn\u00f3stico e progn\u00f3stico: um tutorial","volume":"92","author":"Sousa","year":"2009","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.ajog.2025.01.044_bib68","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.fertnstert.2014.10.033","article-title":"Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more anti-M\u00fcllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study","volume":"103","author":"Bhide","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2025.01.044_bib69","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.fertnstert.2015.06.024","article-title":"Two new automated, compared with two enzyme-linked immunosorbent, antim\u00fcllerian hormone assays","volume":"104","author":"Nelson","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2025.01.044_bib70","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-M\u00fcllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2025.01.044_bib71","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/humrep\/dev127","article-title":"Performance of the two new fully automated anti-M\u00fcllerian hormone immunoassays compared with the clinical standard assay","volume":"30","author":"Van Helden","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2025.01.044_bib72","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.rbmo.2019.11.013","article-title":"Ethnic discordance in serum anti-M\u00fcllerian hormone in healthy women: a population study from China and Europe","volume":"40","author":"Nelson","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2025.01.044_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12559","article-title":"The relationship between anti-M\u00fcllerian hormone, body mass index and weight loss: a review of the literature","volume":"12","author":"Kloos","year":"2022","journal-title":"Clin Obes"},{"key":"10.1016\/j.ajog.2025.01.044_bib74","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12020-018-1756-4","article-title":"The relationship between anti-M\u00fcllerian hormone serum level and body mass index in a large cohort of infertile patients","volume":"63","author":"Albu","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.ajog.2025.01.044_bib75","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.3390\/ijms20102519","article-title":"Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease","volume":"20","author":"Parida","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajog.2025.01.044_bib76","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1210\/en.2006-0679","article-title":"Adiponectin induces periovulatory changes in ovarian follicular cells","volume":"147","author":"Ledoux","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2025.01.044_bib77","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.contraception.2009.10.004","article-title":"Antimullerian hormone and obesity: insights in oral contraceptive users","volume":"81","author":"Steiner","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2025.01.044_bib78","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1111\/jog.15233","article-title":"Updated meta-analysis on the diagnostic accuracy of serum anti-Mullerian hormone in poly cystic ovary syndrome involving 13 509 subjects","volume":"48","author":"Anand","year":"2022","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2025.01.044_bib79","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2013-1393","article-title":"Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data","volume":"98","author":"Iliodromiti","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2025.01.044_bib80","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.4158\/EP-2019-0098","article-title":"Diagnostic value of anti-m\u00fcllerian hormone as a biomarker for polycystic ovary syndrome: a meta-analysis update","volume":"25","author":"Zhao","year":"2019","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ajog.2025.01.044_bib81","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/09513590.2021.1943344","article-title":"Challenges in diagnosis of polycystic ovary syndrome in adolescence","volume":"37","author":"Asanidze","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2025.01.044_bib82","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.4","author":"Higgins","year":"2023"},{"key":"10.1016\/j.ajog.2025.01.044_bib83","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00404-024-07408-2","article-title":"PCOS phenotype focus: phenotype D under the magnifying glass","volume":"309","author":"Myers","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2025.01.044_bib84","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/humrep\/deaa005","article-title":"Clinicians' perspectives on diagnosing polycystic ovary syndrome in Australia: a qualitative study","volume":"35","author":"Copp","year":"2020","journal-title":"Hum Reprod"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825000778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825000778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:38:56Z","timestamp":1762079936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937825000778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0002937825000778"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2025.01.044","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-M\u00fcllerian hormone as a diagnostic marker of polycystic ovary syndrome: a systematic review with meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2025.01.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}